179 related articles for article (PubMed ID: 14761932)
1. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4.
Vroon A; Heijnen CJ; Lombardi MS; Cobelens PM; Mayor F; Caron MG; Kavelaars A
J Leukoc Biol; 2004 May; 75(5):901-9. PubMed ID: 14761932
[TBL] [Abstract][Full Text] [Related]
2. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
3. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.
Sato K; Kawasaki H; Morimoto C; Yamashima N; Matsuyama T
J Immunol; 2002 Jun; 168(12):6263-72. PubMed ID: 12055240
[TBL] [Abstract][Full Text] [Related]
4. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.
Ishida Y; Kimura A; Kondo T; Hayashi T; Ueno M; Takakura N; Matsushima K; Mukaida N
Am J Pathol; 2007 Mar; 170(3):843-54. PubMed ID: 17322370
[TBL] [Abstract][Full Text] [Related]
5. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
6. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus.
Oppermann M; Mack M; Proudfoot AE; Olbrich H
J Biol Chem; 1999 Mar; 274(13):8875-85. PubMed ID: 10085131
[TBL] [Abstract][Full Text] [Related]
8. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
9. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis.
Hecht I; Cahalon L; Hershkoviz R; Lahat A; Franitza S; Lider O
Int Immunol; 2003 Jan; 15(1):29-38. PubMed ID: 12502723
[TBL] [Abstract][Full Text] [Related]
10. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice.
Moreno C; Gustot T; Nicaise C; Quertinmont E; Nagy N; Parmentier M; Le Moine O; Devière J; Louis H
Hepatology; 2005 Oct; 42(4):854-62. PubMed ID: 16175603
[TBL] [Abstract][Full Text] [Related]
11. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vroon A; Kavelaars A; Limmroth V; Lombardi MS; Goebel MU; Van Dam AM; Caron MG; Schedlowski M; Heijnen CJ
J Immunol; 2005 Apr; 174(7):4400-6. PubMed ID: 15778405
[TBL] [Abstract][Full Text] [Related]
13. Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression.
Willets JM; Parent JL; Benovic JL; Kelly E
J Neurochem; 1999 Nov; 73(5):1781-9. PubMed ID: 10537035
[TBL] [Abstract][Full Text] [Related]
14. Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
Dong HF; Wigmore K; Carrington MN; Dean M; Turpin JA; Howard OM
Genes Immun; 2005 Oct; 6(7):609-19. PubMed ID: 16015368
[TBL] [Abstract][Full Text] [Related]
15. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
[TBL] [Abstract][Full Text] [Related]
16. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
17. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes.
Hornung F; Scala G; Lenardo MJ
J Immunol; 2000 Jun; 164(12):6180-7. PubMed ID: 10843668
[TBL] [Abstract][Full Text] [Related]
19. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
[TBL] [Abstract][Full Text] [Related]
20. Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes.
Heijink IH; Vellenga E; Oostendorp J; de Monchy JG; Postma DS; Kauffman HF
Am J Physiol Lung Cell Mol Physiol; 2005 Jul; 289(1):L53-9. PubMed ID: 15749741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
